Lee D Cranmer

  • 3633 Citations
  • 27 h-Index
1991 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1991 2019

  • 3633 Citations
  • 27 h-Index
  • 62 Article
  • 3 Review article
Filter
Article
2019
1 Citation (Scopus)

Systemic Interferon-g Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a phase 0 clinical trial

Zhang, S., Kohli, K., Graeme Black, R., Yao, L., Spadinger, S. M., He, Q., Pillarisetty, V. G., Cranmer, L. D., Van Tine, B. A., Yee, C., Pierce, R. H., Riddell, S. R., Jones, R. L. & Pollack, S. M., Jan 1 2019, In : Cancer Immunology Research. 7, 8, p. 1237-1243 7 p.

Research output: Contribution to journalArticle

Interferons
Synovial Sarcoma
Clinical Trials
Liposarcoma
T-Lymphocytes
2018
5 Citations (Scopus)

A multi-center phase II study of high dose interleukin-2 sequenced with vemurafenib in patients with BRAF-V600 mutation positive metastatic melanoma

Clark, J. I., Singh, J., Ernstoff, M. S., Lao, C. D., Flaherty, L. E., Logan, T. F., Curti, B., Agarwala, S. S., Taback, B., Cranmer, L. D., Lutzky, J., Luna, T. L., Aung, S. & Lawson, D. H., Jul 27 2018, In : Journal for ImmunoTherapy of Cancer. 6, 1, 76.

Research output: Contribution to journalArticle

Interleukin-2
Melanoma
Mutation
Antigen Presentation
Neoplasm Antigens
4 Citations (Scopus)

Economic Evaluation of Talimogene Laherparepvec Plus Ipilimumab Combination Therapy vs Ipilimumab Monotherapy in Patients with Advanced Unresectable Melanoma

Almutairi, A. R., Alkhatib, N. S., Oh, M., Curiel, C. N., Babiker, H. M., Cranmer, L. D., McBride, A. & Abraham, I. L., Jan 1 2018, (Accepted/In press) In : JAMA Dermatology.

Research output: Contribution to journalArticle

Disease-Free Survival
Cost-Benefit Analysis
Melanoma
Quality-Adjusted Life Years
Costs and Cost Analysis
19 Citations (Scopus)

Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients

Zager, J. S., Gastman, B. R., Leachman, S., Gonzalez, R. C., Fleming, M. D., Ferris, L. K., Ho, J., Miller, A. R., Cook, R. W., Covington, K. R., Meldi-Plasseraud, K., Middlebrook, B., Kaminester, L. H., Greisinger, A., Estrada, S. I., Pariser, D. M., Cranmer, L. D., Messina, J. L., Vetto, J. T., Wayne, J. D. & 3 others, Delman, K. A., Lawson, D. H. & Gerami, P., Feb 5 2018, In : BMC Cancer. 18, 1, 130.

Research output: Contribution to journalArticle

Transcriptome
Melanoma
Skin
Neoplasm Metastasis
Recurrence
2 Citations (Scopus)

Response to PD1 inhibition in conventional chondrosarcoma 11 Medical and Health Sciences 1103 Clinical Sciences 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis

Wagner, M. J., Ricciotti, R. W., Mantilla, J., Loggers, E. T., Pollack, S. M. & Cranmer, L. D., Sep 25 2018, In : Journal for ImmunoTherapy of Cancer. 6, 1, 94.

Research output: Contribution to journalArticle

Chondrosarcoma
Carcinogenesis
Health
Tumor Burden
Disease Progression
2017
3 Citations (Scopus)

16S rRNA gene sequencing on a benchtop sequencer: accuracy for identification of clinically important bacteria

Watts, G. S., Youens-Clark, K., Slepian, M. J., Wolk, D., Oshiro, M. M., Metzger, G. S., Dhingra, D., Cranmer, L. D. & Hurwitz, B. L., Dec 1 2017, In : Journal of Applied Microbiology. 123, 6, p. 1584-1596 13 p.

Research output: Contribution to journalArticle

rRNA Genes
Bacteria
Ions
Databases
Metagenomics
18 Citations (Scopus)

Angiosarcoma treated successfully with anti-PD-1 therapy - a case report

Sindhu, S., Gimber, L. H., Cranmer, L. D., McBride, A. & Kraft, A., Jul 18 2017, In : Journal for ImmunoTherapy of Cancer. 5, 1, 58.

Research output: Contribution to journalArticle

Hemangiosarcoma
Sarcoma
Immunotherapy
Programmed Cell Death 1 Receptor
Neoplasms
47 Citations (Scopus)

Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial

Tap, W. D., Papai, Z., Van Tine, B. A., Attia, S., Ganjoo, K. N., Jones, R. L., Schuetze, S., Reed, D., Chawla, S. P., Riedel, R. F., Krarup-Hansen, A., Toulmonde, M., Ray-Coquard, I., Hohenberger, P., Grignani, G., Cranmer, L. D., Okuno, S., Agulnik, M., Read, W., Ryan, C. W. & 8 others, Alcindor, T., del Muro, X. F. G., Budd, G. T., Tawbi, H., Pearce, T., Kroll, S., Reinke, D. K. & Schöffski, P., Aug 1 2017, In : The Lancet Oncology. 18, 8, p. 1089-1103 15 p.

Research output: Contribution to journalArticle

Sarcoma
Doxorubicin
Survival
TH 302
Therapeutics
29 Citations (Scopus)

Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma

Hamid, O., Puzanov, I., Dummer, R., Schachter, J., Daud, A., Schadendorf, D., Blank, C., Cranmer, L. D., Robert, C., Pavlick, A. C., Gonzalez, R., Hodi, F. S., Ascierto, P. A., Salama, A. K. S., Margolin, K. A., Gangadhar, T. C., Wei, Z., Ebbinghaus, S., Ibrahim, N. & Ribas, A., Nov 1 2017, In : European Journal of Cancer. 86, p. 37-45 9 p.

Research output: Contribution to journalArticle

Melanoma
Research Personnel
Drug Therapy
Survival
Confidence Intervals
14 Citations (Scopus)

Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIMSM

Clark, J. I., Wong, M. K. K., Kaufman, H. L., Daniels, G. A., Morse, M. A., McDermott, D. F., Agarwala, S. S., Lewis, L. D., Stewart, J. H., Vaishampayan, U., Curti, B., Gonzalez, R., Lutzky, J., Rudraptna, V., Cranmer, L. D., Jeter, J. M., Hauke, R. J., Miletello, G., Milhem, M. M., Amin, A. & 14 others, Richart, J. M., Fishman, M., Hallmeyer, S., Patel, S. P., Van Veldhuizen, P., Agarwal, N., Taback, B., Treisman, J. S., Ernstoff, M. S., Perritt, J. C., Hua, H., Rao, T. B., Dutcher, J. P. & Aung, S., Feb 1 2017, In : Clinical Genitourinary Cancer. 15, 1, p. 31-41.e4

Research output: Contribution to journalArticle

Survival Analysis
Renal Cell Carcinoma
Immunotherapy
Interleukin-2
Clinical Trials

Recurrent Osteosarcoma Presenting as an Isolated Bone Marrow Relapse

Liu, J., Cranmer, L. D., Larsen, B. T., Kuo, P. H. & Kopp, L. M., 2017, In : Journal of Pediatric Hematology/Oncology. 39, 4, p. 302-305 4 p.

Research output: Contribution to journalArticle

Osteosarcoma
Jaw
Bone Marrow
Recurrence
Femur
45 Citations (Scopus)

T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas

Pollack, S. M., He, Q., Yearley, J. H., Emerson, R., Vignali, M., Zhang, Y., Redman, M. W., Baker, K. K., Cooper, S., Donahue, B., Loggers, E. T., Cranmer, L. D., Spraker, M. B., Seo, Y. D., Pillarisetty, V. G., Ricciotti, R. W., Hoch, B. L., Mcclanahan, T. K., Murphy, E., Blumenschein, W. M. & 4 others, Townson, S. M., Benzeno, S., Riddell, S. R. & Jones, R. L., 2017, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Programmed Cell Death 1 Receptor
Sarcoma
Ligands
T-Lymphocytes
Liposarcoma
5 Citations (Scopus)

Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600E

Hallmeyer, S., Gonzalez, R., Lawson, D. H., Cranmer, L. D., Linette, G. P., Puzanov, I., Taback, B., Cowey, C. L., Ribas, A., Daniels, G. A., Moore, T., Gibney, G. T., Tawbi, H., Whitman, E., Lee, G., Mun, Y., Liu, S. & Hamid, O., 2017, In : Melanoma Research. 27, 6, p. 585-590 6 p.

Research output: Contribution to journalArticle

Exons
Melanoma
Mutation
Therapeutics
Confidence Intervals
2016
2 Citations (Scopus)
Clinical Trials
Investigational Drugs
Drug Approval
Sensitivity and Specificity
Resource Allocation
28 Citations (Scopus)

Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma

Schadendorf, D., Dummer, R., Hauschild, A., Robert, C., Hamid, O., Daud, A., van den Eertwegh, A., Cranmer, L. D., O'Day, S., Puzanov, I., Schachter, J., Blank, C., Salama, A., Loquai, C., Mehnert, J. M., Hille, D., Ebbinghaus, S., Kang, S. P., Zhou, W. & Ribas, A., Nov 1 2016, In : European Journal of Cancer. 67, p. 46-54 9 p.

Research output: Contribution to journalArticle

Melanoma
Quality of Life
Drug Therapy
Health Status
ipilimumab
80 Citations (Scopus)

Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial

Andtbacka, R. H. I., Ross, M., Puzanov, I., Milhem, M., Collichio, F., Delman, K. A., Amatruda, T., Zager, J. S., Cranmer, L. D., Hsueh, E., Chen, L., Shilkrut, M. & Kaufman, H. L., Dec 1 2016, In : Annals of Surgical Oncology. 23, 13, p. 4169-4177 9 p.

Research output: Contribution to journalArticle

Phase III Clinical Trials
Melanoma
Immunotherapy
Immunity
Neoplasms
2 Citations (Scopus)

Quantitative histopathology identifies patients with thin melanomas who are at risk for metastases

Glazer, E. S., Bartels, P. H., Lian, F., Kha, S. T., Morgan, S. S., da Silva, V. D., Yozwiak, M. L., Bartels, H. G., Cranmer, L. D., de Oliveira, J. K., Alberts, D. S., Warneke, J. A. & Krouse, R. S., Jan 19 2016, (Accepted/In press) In : Melanoma Research.

Research output: Contribution to journalArticle

Melanoma
Neoplasm Metastasis
Phenotype
Mitotic Index
Therapeutics
7 Citations (Scopus)

Targeting gastrointestinal stromal tumors: The role of regorafenib

Schroeder, B., Li, Z., Cranmer, L. D., Jones, R. L. & Pollack, S. M., May 20 2016, In : OncoTargets and Therapy. 9, p. 3009-3016 8 p.

Research output: Contribution to journalArticle

Gastrointestinal Stromal Tumors
Standard of Care
Natural History
Protein-Tyrosine Kinases
regorafenib
2015
1 Citation (Scopus)

Characterization of a novel radiation-induced sarcoma cell line

Lang, J., Zhu, W., Nokes, B., Sheth, G., Novak, P., Fuchs, L., Watts, G. S., Futscher, B. W., Mineyev, N., Ring, A., Lebeau, L., Nagle, R. B. & Cranmer, L. D., May 1 2015, In : Journal of Surgical Oncology. 111, 6, p. 669-682 14 p.

Research output: Contribution to journalArticle

Sarcoma
Radiation
Cell Line
Neoplasms
SCID Mice
36 Citations (Scopus)

Ipilimumab granulomatous interstitial nephritis

Thajudeen, B., Madhrira, M., Bracamonte, E. & Cranmer, L. D., May 16 2015, In : American Journal of Therapeutics. 22, 3, p. e84-e87

Research output: Contribution to journalArticle

Interstitial Nephritis
Kidney
Renal Insufficiency
Exanthema
Melanoma
769 Citations (Scopus)

Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): A randomised, controlled, phase 2 trial

Ribas, A., Puzanov, I., Dummer, R., Schadendorf, D., Hamid, O., Robert, C., Hodi, F. S., Schachter, J., Pavlick, A. C., Lewis, K. D., Cranmer, L. D., Blank, C. U., O'Day, S. J., Ascierto, P. A., Salama, A. K. S., Margolin, K. A., Loquai, C., Eigentler, T. K., Gangadhar, T. C., Carlino, M. S. & 16 others, Agarwala, S. S., Moschos, S. J., Sosman, J. A., Goldinger, S. M., Shapira-Frommer, R., Gonzalez, R., Kirkwood, J. M., Wolchok, J. D., Eggermont, A., Li, X. N., Zhou, W., Zernhelt, A. M., Lis, J., Ebbinghaus, S., Kang, S. P. & Daud, A., Aug 1 2015, In : The Lancet Oncology. 16, 8, p. 908-918 11 p.

Research output: Contribution to journalArticle

Melanoma
Research Personnel
Drug Therapy
Disease-Free Survival
Carboplatin
7 Citations (Scopus)

Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer

Sarantopoulos, J., Mita, M. M., Birrer, M. J., Cranmer, L. D., Campos, L. T., Zhang, X., Bristow, P., Kaito, H., Strout, V. & Camacho, L. H., Oct 27 2015, (Accepted/In press) In : Targeted Oncology.

Research output: Contribution to journalArticle

Epidermal Growth Factor
Heparin
Intercellular Signaling Peptides and Proteins
Monoclonal Antibodies
Neoplasms
813 Citations (Scopus)

Talimogene laherparepvec improves durable response rate in patients with advanced melanoma

Andtbacka, R. H. I., Kaufman, H. L., Collichio, F., Amatruda, T., Senzer, N., Chesney, J., Delman, K. A., Spitler, L. E., Puzanov, I., Agarwala, S. S., Milhem, M., Cranmer, L. D., Curti, B., Lewis, K., Ross, M., Guthrie, T., Linette, G. P., Daniels, G. A., Harrington, K., Middleton, M. R. & 9 others, Miller, W. H., Zager, J. S., Ye, Y., Yao, B., Li, A., Doleman, S., Van Der Walde, A., Gansert, J. & Coffin, R. S., Sep 1 2015, In : Journal of Clinical Oncology. 33, 25, p. 2780-2788 9 p.

Research output: Contribution to journalArticle

Melanoma
Granulocyte-Macrophage Colony-Stimulating Factor
Immunotherapy
Survival
Chills
2014
33 Citations (Scopus)

A single-arm, open-label, expanded access study of vemurafenib in patients with metastatic melanoma in the United States

Flaherty, L., Hamid, O., Linette, G., Schuchter, L., Hallmeyer, S., Gonzalez, R., Cowey, C. L., Pavlick, A., Kudrik, F., Curti, B., Lawson, D., Chapman, P. B., Margolin, K., Ribas, A., McDermott, D., Flaherty, K., Cranmer, L. D., Hodi, F. S., Day, B. M., Linke, R. & 1 others, Hainsworth, J., Jan 2014, In : Cancer Journal. 20, 1, p. 18-24 7 p.

Research output: Contribution to journalArticle

Melanoma
Neoplasm Metastasis
PLX4032
Brain
Mutation
79 Citations (Scopus)

Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma

Chawla, S. P., Cranmer, L. D., Van Tine, B. A., Reed, D. R., Okuno, S. H., Butrynski, J. E., Adkins, D. R., Hendifar, A. E., Kroll, S. & Ganjoo, K. N., Oct 10 2014, In : Journal of Clinical Oncology. 32, 29, p. 3299-3306 8 p.

Research output: Contribution to journalArticle

Prodrugs
Sarcoma
Doxorubicin
Safety
Disease-Free Survival
6 Citations (Scopus)
Synovial Sarcoma
Chemical activation
Melphalan
Cells
Doxorubicin
2013
10 Citations (Scopus)

A novel therapeutic combination approach for treating multiple vemurafenib-induced keratoacanthomas: Systemic acitretin and intralesional fluorouracil

LaPresto, L., Cranmer, L. D., Morrison, L., Erickson, C. P. & Curiel, C. N., Mar 2013, In : JAMA Dermatology. 149, 3, p. 279-281 3 p.

Research output: Contribution to journalArticle

Keratolytic Agents
Proto-Oncogene Proteins B-raf
Acitretin
Intralesional Injections
Keratoacanthoma
3 Citations (Scopus)

Pleomorphic rhabdomyosarcoma in a patient with hereditary nonpolyposis colorectal cancer

Cranmer, L. D., Chen, C. C., Morgan, S., Martino, G. & Ray, J., Mar 1 2013, In : Journal of Clinical Oncology. 31, 7

Research output: Contribution to journalArticle

Signal Transducing Adaptor Proteins
Antineoplastic Combined Chemotherapy Protocols
DNA Repair Enzymes
Large-Core Needle Biopsy
Hereditary Nonpolyposis Colorectal Neoplasms
138 Citations (Scopus)

Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy.

Demetri, G. D., Chawla, S. P., Ray-Coquard, I., Le Cesne, A., Staddon, A. P., Milhem, M. M., Penel, N., Riedel, R. F., Bui-Nguyen, B., Cranmer, L. D., Reichardt, P., Bompas, E., Alcindor, T., Rushing, D., Song, Y., Lee, R. M., Ebbinghaus, S., Eid, J. E., Loewy, J. W., Haluska, F. G. & 2 others, Dodion, P. F. & Blay, J. Y., Jul 1 2013, In : Journal of Clinical Oncology. 31, 19, p. 2485-2492 8 p.

Research output: Contribution to journalArticle

Sirolimus
Sarcoma
Placebos
Drug Therapy
Disease-Free Survival
2012

Erythematous annular plaques on the trunk

LaPresto, L., Cranmer, L. D., Erickson, C. P., Morrison, L., Curiel, C. N. & Cohen, J. A., Apr 2012, In : Archives of Dermatology. 148, 4

Research output: Contribution to journalArticle

Multiple Primary Neoplasms
Fatal Outcome
Skin Neoplasms
Melanoma
Prostatic Neoplasms
8 Citations (Scopus)
Melanoma
Drug Therapy
Investigational Therapies
Immunosuppressive Agents
Therapeutics
1 Citation (Scopus)
Patient treatment
Disease-Free Survival
Tomography
Tumors
Melanoma
44 Citations (Scopus)

Radiation-induced sarcoma of the breast: A systematic review

Sheth, G. R., Cranmer, L. D., Smith, B. D., Grasso-LeBeau, L. & Lang, J. E., 2012, In : Oncologist. 17, 3, p. 405-418 14 p.

Research output: Contribution to journalArticle

Sarcoma
Breast
Radiation
Adjuvant Chemotherapy
Practice Guidelines
35 Citations (Scopus)

Roles for endothelin receptor B and BCL2A1 in spontaneous CNS metastasis of melanoma

Cruz-Muñoz, W., Jaramillo, M. L., Man, S., Xu, P., Banville, M., Collins, C., Nantel, A., Francia, G., Morgan, S. S., Cranmer, L. D., O'Connor-McCourt, M. D. & Kerbel, R. S., Oct 1 2012, In : Cancer Research. 72, 19, p. 4909-4919 11 p.

Research output: Contribution to journalArticle

Endothelin B Receptors
Melanoma
Central Nervous System
Neoplasm Metastasis
A 192621
65 Citations (Scopus)

TH-302, a hypoxia-activated prodrug with broad in vivo preclinical combination therapy efficacy: Optimization of dosing regimens and schedules

Liu, Q., Sun, J. D., Wang, J., Ahluwalia, D., Baker, A. F., Cranmer, L. D., Ferraro, D., Wang, Y., Duan, J. X., Ammons, W. S., Curd, J. G., Matteucci, M. D. & Hart, C. P., Jun 2012, In : Cancer Chemotherapy and Pharmacology. 69, 6, p. 1487-1498 12 p.

Research output: Contribution to journalArticle

Prodrugs
Appointments and Schedules
irinotecan
temozolomide
docetaxel
2011
99 Citations (Scopus)

A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma

Lewis, K. D., Samlowski, W., Ward, J., Catlett, J., Cranmer, L. D., Kirkwood, J., Lawson, D., Whitman, E. & Gonzalez, R., Feb 2011, In : Investigational New Drugs. 29, 1, p. 161-166 6 p.

Research output: Contribution to journalArticle

Melanoma
Inhibitor of Apoptosis Proteins
Melanocytes
Arthralgia
Back Pain
43 Citations (Scopus)

A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors

Weber, J. S., Vogelzang, N. J., Ernstoff, M. S., Goodman, O. B., Cranmer, L. D., Marshall, J. L., Miles, S., Rosario, D., Diamond, D. C., Qiu, Z., Obrocea, M. & Bot, A., Sep 2011, In : Journal of Immunotherapy. 34, 7, p. 556-567 12 p.

Research output: Contribution to journalArticle

Melanoma-Specific Antigens
Vaccines
Neoplasm Antigens
Neoplasms
Plasmids
208 Citations (Scopus)

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

Hersh, E. M., O'Day, S. J., Powderly, J., Khan, K. D., Pavlick, A. C., Cranmer, L. D., Samlowski, W. E., Nichol, G. M., Yellin, M. J. & Weber, J. S., Jun 2011, In : Investigational New Drugs. 29, 3, p. 489-498 10 p.

Research output: Contribution to journalArticle

Dacarbazine
Multicenter Studies
Melanoma
Drug Therapy
ipilimumab
51 Citations (Scopus)

A phase i study of the safety and pharmacokinetics of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma

Ganjoo, K. N., Cranmer, L. D., Butrynski, J. E., Rushing, D., Adkins, D., Okuno, S. H., Lorente, G., Kroll, S., Langmuir, V. K. & Chawla, S. P., Jun 2011, In : Oncology. 80, 1-2, p. 50-56 7 p.

Research output: Contribution to journalArticle

Prodrugs
Sarcoma
Doxorubicin
Pharmacokinetics
Safety
17 Citations (Scopus)

Metastatic cutaneous squamous cell carcinoma responding to erlotinib therapy

Engelhardt, C., Curiel, C. N., Warneke, J. A. & Cranmer, L. D., Jul 2011, In : Journal of the American Academy of Dermatology. 65, 1, p. 237-238 2 p.

Research output: Contribution to journalArticle

Local Neoplasm Recurrences
Drug Dose Response Relationship
Drug Administration Schedule
Quinazolines
Lymphatic Metastasis
25 Citations (Scopus)

Multiple primary cutaneous melanomas in Li-Fraumeni syndrome

Curiel, C. N., Speetzen, L. S., Cranmer, L. D., Warneke, J. A. & Loescher, L. J., Feb 2011, In : Archives of Dermatology. 147, 2, p. 248-250 3 p.

Research output: Contribution to journalArticle

Multiple Primary Neoplasms
Li-Fraumeni Syndrome
p53 Genes
Skin Neoplasms
Melanoma
8 Citations (Scopus)

Systematic therapy for unresectable or metastatic soft-tissue sarcomas: Past, present, and future

Morgan, S. S. & Cranmer, L. D., Aug 2011, In : Current Oncology Reports. 13, 4, p. 331-349 19 p.

Research output: Contribution to journalArticle

Sarcoma
Doxorubicin
Therapeutics
Cytotoxins
Drug Therapy
2010
1 Citation (Scopus)

Melanomas radioresistant reputation challenged

Cranmer, L. D., Jun 2010, In : Oncology (Williston Park, N.Y.). 24, 7

Research output: Contribution to journalArticle

Melanoma

Melanoma's radioresistant reputation challenged.

Cranmer, L. D., Jun 2010, In : Oncology (Williston Park, N.Y.). 24, 7, p. 656 1 p.

Research output: Contribution to journalArticle

Melanoma
Neoplasm Metastasis
2 Citations (Scopus)

The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?

Chapman, P., Cranmer, L. D., Dixon, W. G., Hyrich, K. L., Patterson, J. R., Symmons, D. P. M., Toporcer, M. & Mastrangelo, M. J., Feb 2010, In : Seminars in Oncology. 37, 1, p. 11-19 9 p.

Research output: Contribution to journalArticle

Antirheumatic Agents
Second Primary Neoplasms
Tumor Necrosis Factor Receptors
Skin Neoplasms
Melanoma
66 Citations (Scopus)

Treatment of unresectable and metastatic cutaneous squamous cell carcinoma

Cranmer, L. D., Engelhardt, C. & Morgan, S. S., Dec 2010, In : Oncologist. 15, 12, p. 1320-1328 9 p.

Research output: Contribution to journalArticle

Squamous Cell Carcinoma
Skin
Isotretinoin
Random Allocation
Interferons
4 Citations (Scopus)

Whole-brain radiation therapy in melanoma: an open question

Cranmer, L. D., Jeter, J. M., Morgan, S. S., Hersh, E. M. & Stea, B., Jan 2010, In : The Lancet Oncology. 11, 1, p. 13 1 p.

Research output: Contribution to journalArticle

Cranial Irradiation
Brain Neoplasms
Patient Selection
Melanoma
Radiotherapy
2009
5 Citations (Scopus)
Local Neoplasm Recurrences
Peritoneal Neoplasms
Antineoplastic Combined Chemotherapy Protocols
Desmoplastic Small Round Cell Tumor
ErbB-2 Receptor
2 Citations (Scopus)

In-transit metastasis from melanoma presenting as lymphangiectasis: A case report

Shekhel, T., Glick, R. M. & Cranmer, L. D., Sep 2009, In : Cutis. 84, 3, p. 151-158 8 p.

Research output: Contribution to journalArticle

Lymphangiectasis
Melanoma
Neoplasm Metastasis
Lower Extremity
Leg
4 Citations (Scopus)
Family Health
Health Personnel
Melanoma
Communication
Mental Competency